Success Stories: Cancer Research Scientist Secures NIW Approval in Less Than Two Months with Premium Processing
Client’s Testimonial:
“Thank you for your message. I am also pleased to work with you on this process.”
On April 1st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Visiting Researcher in the Field of Cancer Pathology (Approval Notice).
General Field: Cancer Pathology
Position at the Time of Case Filing: Visiting Researcher
Country of Residence at the Time of Filing: Japan
Approval Notice Date: April 1st, 2025
Processing Time: 1 month, 24 days (Premium Processing Requested)
Case Summary:
At North America Immigration Law Group, we are proud to celebrate another rapid success story. A highly accomplished cancer researcher recently obtained I-140 NIW (National Interest Waiver) approval in just 1 month and 24 days through direct Premium Processing, thanks to her groundbreaking work and our dedicated petition strategy.
Client’s Field and Research Focus
Our client is a specialist in cancer pathology. Her proposed endeavor focuses on developing advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. Her work aims to enhance early detection, personalize treatment plans, and improve survival outcomes for cancer patients.
Currently, she is engaged in cancer research and plans to continue developing innovative solutions in the biotech and pharmaceutical industry.
Petition Category and Achievements
Filed under the EB-2 NIW category, her case stood out based on:
● 11 peer-reviewed journal articles and 13 first-authored conference abstracts. ● 131 total citations according to Google Scholar, reflecting her wide impact in the academic community. ● Completed 3 peer reviews for academic journals in the field of dental sciences. Recognition for high-impact research, with two of her articles ranked among the top 20% most cited papers in Clinical Medicine for their respective years. ● Previous research funding from prestigious organizations such as the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT).
Her publications appeared in prominent journals like Acta Neuropathologica Communications and Cancers, highlighting her distinguished position in her field.Demonstrating National Importance
We demonstrated how her research supports the United States’ public health and economic interests by:
➔ Addressing cancer, one of the leading causes of death in the U.S., and advancing early detection strategies that could save billions in healthcare costs. ➔ Contributing to innovations in the U.S. cancer therapeutics market, a sector projected to grow to over $120 billion by 2032. ➔ Enhancing biomedical research and precision medicine, in alignment with national priorities to improve health outcomes and drive economic resilience.
An excerpt from one of her recommendation letters eloquently captured her impact:"[Client] has significantly advanced our understanding of cancer biomarkers and optimized combination therapies, providing critical insights that are essential for developing effective treatments and reducing the cancer burden in the United States."
Outcome
Through her strong research profile, significant peer recognition, and our expertly crafted legal arguments, the client’s NIW petition was approved swiftly without any requests for additional evidence.
We are honored to have played a part in her success story and are confident she will continue to contribute meaningfully to medical innovation and public health advancements in the United States.